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OBJECTIVES The goal of this study was to investigate the hemodynamic and circulatory adjustments to
extracorporeal ultrafiltration (UF) in refractory congestive heart failure (rCHF).
BACKGROUND In rCHF, UF allows clinical improvement and restores diuretic efficacy. However, in the
course of a UF session, patients are exposed to rapid variations of body fluid composition so
that, as fluid is withdrawn from the intravascular compartment, hypotension or even shock
could occur.
METHODS In 24 patients with rCHF undergoing UF, we measured, after every liter of plasma water
removed, hemodynamics, blood gas analysis (in both systemic and pulmonary arteries),
plasma volume changes (PV) and plasma refilling rate (PRR). The PV and PRR were
calculated by considering hematocrit and ultrafiltrate volume.
RESULTS In all patients, UF was performed safely, without side effects or hemodynamic instability
(ultrafiltrate 5 4,880 6 896 ml). Mean right atrial, pulmonary artery and wedge pressures
progressively reduced during the procedure. Cardiac output increased at the end of the
procedure and, to a greater extent, 24 h later, in relation to the increase of stroke volume.
Heart rate and systemic vascular resistance did not increase, and other peripheral biochemical
parameters did not worsen during UF. Intravascular volume remained stable throughout the
entire duration of the procedure, indicating that a proportional volume of fluid was refilled
from the congested parenchyma.
CONCLUSIONS In patients with rCHF, subtraction of plasma water by UF is associated with hemody-
namic improvement. Fluid refilling from the overhydrated interstitium is the major compen-
satory mechanism for intravascular fluid removal, and hypotension does not occur when
plasma refilling rate is adequate to prevent hypovolemia. (J Am Coll Cardiol 2001;38:963–8)
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Refractory congestive heart failure (rCHF) usually repre-
sents the end stage of heart failure in which hypotension and
oliguria, leading to progressive generalized edema, occur.
Refractory CHF is considered the end product of a vicious
circle in which reduced cardiac output and impaired salt and
water renal excretion have a negative impact on each other
(1,2). As a consequence of progressive resistance to larger
doses of diuretics, kidney replacement therapies have gained
wide acceptance in the management of refractoriness.
Among these, extracorporeal ultrafiltration (UF) is particu-
larly helpful because it allows for sustained clinical improve-
ment. Indeed, after UF, pulmonary and peripheral edema
reduce, mechanical lung function improves, right atrial
pressure and pulmonary wedge pressure decrease, neurohu-
moral activation is reset toward a more physiological con-
dition and diuretic efficacy is restored (3–7).
In the course of a UF session, patients are exposed to
rapid variations of body fluid composition. Since fluid is
withdrawn from the intravascular compartment, blood vol-
ume falls during this process. The transient reduction of
blood volume elicits compensatory mechanisms, namely the
process of intravascular refill, which are aimed at minimiz-
ing this reduction (8). Refill from the overhydrated inter-
stitium depends on fluid movement through the capillary
walls, a result of hydrostatic and oncotic pressure gradient
changes between the intravascular and the interstitial
compartments (9). Cardiovascular reaction to transient hy-
povolemia is mainly mediated by the sympathetic and
renin-angiotensin systems (1,10). Often, however, these
mechanisms are already maximally utilized or even ex-
hausted in rCHF, and, when the cardiovascular system fails
to respond to hypovolemia, hypotension and shock progres-
sively occur. The circulatory response of patients with rCHF
undergoing UF is not completely understood. Although UF
is considered a safe procedure and severely ill patients
tolerate UF better than hemodialysis, a wide incidence rate
of hypotension and treatment failure has been reported
(11,12). This can be due to differences in the patients’
clinical characteristics, technique utilized (venovenous vs.
arterovenous circuit, ultrafiltration vs. hemofiltration, etc.)
or amount and speed of fluid removal. All these factors can
influence the circulatory responses to fluid subtraction and,
finally, the clinical outcome of patients with rCHF.
We performed this study in order to investigate whether
it is possible to preserve blood volume and hemodynamic
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stability during UF through an adequate plasma refilling
rate, in spite of the removal of large amounts of fluid.
METHODS
Study patients. The study included 24 patients (18 men
and 6 women, mean age 64 6 11 years) with rCHF (New
York Heart Association [NYHA] functional class IV).
Seventeen patients had ischemic heart disease, and seven
patients had idiopathic dilated cardiomyopathy. All patients
had symptoms of dyspnea with radiological evidence of
pulmonary venous congestion and cardiomegaly, recent
body weight gain (.5 kg in the last month), generalized
edema and ingravescent oligoanuria. All patients were in the
cardiac intensive care unit for treatment of heart failure at
the time of the study. Long-term medications included
digoxin (n 5 11), diuretics (n 5 24), angiotensin-
converting enzyme inhibitors (n 5 15), nitrates (n 5 8) and
amiodarone (n 5 12). Short-term medications used for
cardiac decompensation included dopamine (n 5 16), do-
butamine (n 5 8) and amrinone (n 5 2) in different
combinations and doses. During the study period, medica-
tions were not changed. The ethical committee of our
institution approved the study, and written informed con-
sent was obtained from each patient after detailed explana-
tion of the technique and the clinical and research purposes
of the study were given.
Study protocol. Hemodynamic studies were performed in
the morning after an overnight fast. All patients had a 7F
triple lumen balloon flotation catheter for measurement of
right atrial, pulmonary artery and pulmonary capillary
wedge pressures. Mixed venous blood for gas analysis was
obtained from the distal port of this catheter. Cardiac
output was determined in triplicate by the thermodilution
method. A radial artery catheter was used to measure
arterial pressure and to obtain arterial blood for determina-
tions of gases. After endovascular procedures, patients were
allowed to rest quietly in the most comfortable position they
could find for at least 1 h before arterial and mixed venous
blood samplings and hemodynamic recordings were per-
formed. Hemodynamic measures included heart rate, mean
systemic blood pressure, mean right atrial pressure, mean
pulmonary artery and wedge blood pressures and cardiac
output. Derived data, namely stroke volume and systemic
and pulmonary vascular resistances, were calculated with
standard formulas. Blood samples were utilized to deter-
mine hemoglobin, PO2, PCO2, pH and hemoglobin satura-
tion (IL482 and IL1306, Instrumentation Laboratories,
Lexington, Massachusetts). Arterial-venous oxygen differ-
ence, oxygen consumption, oxygen delivery and oxygen
extraction ratio were also obtained by using standard for-
mulas (13). The changes in plasma volume (DPV) during
UF were calculated from changes in hematocrit (Ht) ac-
cording to the following formula (14): DPV 5 100/(100 2
Htpre) 3 [100 (Htpre 2 Htpost)]/Htpost where pre and
post are the two time points considered. Plasma refilling rate
(PRR, ml/min), which represents a measurement of the
fluid volume transport from the interstitium to the intra-
vascular space during ultrafiltration, is the ultrafiltrate vol-
ume/time, where time is the duration of ultrafiltration if
DPV 5 0. When PRR equals ultrafiltration rate, blood
volume stability is preserved.
In all patients, hemodynamic data were obtained before
UF and repeated after 1 L, 2 L, 3 L and 4 L of UF, at the
end of the procedure and 24 h later. Hematocrit for DPV
estimation was obtained for every liter of ultrafiltrate, up to
the end of UF and 24 h later.
Ultrafiltration. Ultrafiltration treatment was performed by
using a B. Braun-Carex Diapact CRRT peristaltic pump
(Mirandola, Italy). During UF, blood is pumped through a
filter (Renaflo HF700, Mirandola, Italy), which is inserted
into an extracorporeal circuit connected to a double lumen
Y-shaped catheter positioned in a femoral vein. A peristaltic
pump was regulated to maintain a blood flow of 100 ml/min
within the circuit. The flow velocity was never changed
during the procedure. In all patients, the procedure was
terminated when Ht was increased by 10% of baseline (more
than 4 L of ultrafiltrate in all cases). A loading bolus of
5,000 IU of heparin was administered inside the circuit
before allowing blood to pass into the filter, and then a
continuous heparin infusion rate of 500 to 1,000 IU/h was
maintained during the UF session.
Statistical analysis. All data are presented as mean 6 SD.
Changes during UF were assessed by repeated measures of
analysis of variance, applying the post-hoc Dunnet adjust-
ments. All statistical analyses were performed using the SPSS
software package. A p value #0.05 was considered significant.
RESULTS
In all patients, the single session of UF was performed safely,
without side effects or hemodynamic instability. The mean
time duration of the procedure was 9 6 3 h, and the total fluid
volume removed was 4,880 6 896 ml (range: 4,300 to 7,000
ml), which, in addition to the increase in urinary output
induced by UF (2,6,15), resulted, 24 h after UF, in a reduction
in body weight of 7.4 6 1.8 kg. After UF, the stage of
congestive heart failure (NYHA classification) improved in all
patients; pulmonary edema was relieved; ascites and peripheral
edema were significantly reduced, and the response to subse-
quent diuretic therapy was enhanced (the mean dose of
furosemide was reduced from 380 6 157 mg/day to 112 6
70 mg/day from the day after UF).
Abbreviations and Acronyms
Ht 5 hematocrit
NYHA 5 New York Heart Association
PRR 5 plasma refilling rate
PV 5 plasma volume
rCHF 5 refractory congestive heart failure
UF 5 extracorporeal ultrafiltration
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During the procedure, as well as in the following 24 h,
patients showed no changes in heart rate, mean systemic
arterial pressure or systemic vascular resistance (Table 1).
Mean right atrial pressure, pulmonary wedge pressure
(Fig. 1) and pulmonary artery pressure (Table 1) progres-
sively reduced. Right atrial and pulmonary wedge pressure
reduction was parallel and on a one to one basis (Fig. 2).
Cardiac output increased at the end of the procedure and, to a
Table 1. Blood Gas Analysis and Hemodynamic Data at Each of Examined Treatment Steps
Before UF 1 L 2 L 3 L 4 L After UF 24 h After UF
pH A 7.44 6 0.04 7.44 6 0.04 7.43 6 0.04 7.44 6 0.03 7.44 6 0.04 7.45 6 0.05 7.47 6 0.07*
V 7.41 6 0.04 7.41 6 0.04 7.41 6 0.05 7.42 6 0.05 7.42 6 0.04 7.42 6 0.04 7.42 6 0.04
PO2 (mm Hg) A 80 6 15 81 6 14 82 6 14 82 6 16 84 6 16 86 6 20* 87 6 17*
V 29 6 5 28 6 5 29 6 5 30 6 4 32 6 4 34 6 5* 35 6 4*
PCO2 (mm Hg) A 35 6 4 35 6 4 34 6 6 35 6 7 34 6 5 33 6 7 33 6 6
V 41 6 4 41 6 4 40 6 5 41 6 5 41 6 5 40 6 5 40 6 4
Sat O2 (%) A 95 6 4 95 6 5 95 6 4 95 6 6 96 6 4 96 6 3 97 6 2*
V 54 6 12 54 6 12 55 6 13 57 6 12 58 6 12* 60 6 13* 64 6 10*
HR (beats/min) 82 6 17 83 6 16 82 6 15 83 6 16 81 6 17 80 6 15 80 6 16
mSAP (mm Hg) 86 6 16 84 6 15 82 6 14 84 6 16 80 6 18 78 6 21 80 6 18
mPAP (mm Hg) 39 6 11 38 6 10 38 6 11 36 6 12 34 6 10* 34 6 11* 30 6 15*
SVR (dyneszszcm25) 1,676 6 465 1,640 6 430 1,682 6 415 1,710 6 515 1,699 6 567 1,701 6 795 1,319 6 412*
PVR (dyneszszcm25) 324 6 160 342 6 173 365 6 184 339 6 165 344 6 178 350 6 188 264 6 148*
VO2 (ml/min/m
2) 127 6 29 126 6 30 128 6 32 128 6 36 127 6 31 128 6 33 132 6 48*
DO2 (ml/min/m
2) 311 6 88 299 6 97 310 6 101 335 6 105 327 6 112 385 6 105* 410 6 134*
ERO2 (%) 43 6 14 42 6 15 41 6 15 38 6 17 39 6 16 33 6 16* 32 6 13*
a-v DO2 (ml/dl) 7 6 2 6.8 6 2 6.7 6 2 6.4 6 2 6.2 6 2* 5.9 6 2* 5.5 6 2*
Data are mean 6 SD. *p , 0.05 vs. before UF.
A 5 arterial blood; a-v DO2 5 arterial-venous oxygen difference; DO2 5 oxygen delivery; ERO2 5 oxygen extraction ratio; HR 5 heart rate; mPAP 5 mean arterial pulmonary
pressure; mSAP 5 mean systemic arterial pressure; PVR 5 pulmonary vascular resistances; SVR 5 systemic vascular resistances; UF 5 ultrafiltration; V 5 mixed venous blood;
VO2 5 oxygen consumption.
Figure 1. Mean pulmonary wedge pressure (PWP), mean right atrial pressure (RAP), cardiac output (CO) and stroke volume (SV) before, during and after
extracorporeal ultrafiltration (UF). *p , 0.01 vs. before ultrafiltration.
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greater extent, 24 h later in relation to the increase of stroke
volume (Fig. 1). Table 1 also shows the derived hemody-
namic and blood gas parameters at each of the examined
steps. No change in all these parameters occurred during
UF, whereas, at the end of the procedure and 24 h later, PO2
and hemoglobin saturation increased. This was more rele-
vant at the venous site.
Intravascular volume, as estimated by hematocrit values,
remained stable throughout the entire time of the treatment
despite the large amount of fluid removed (Fig. 3). This
indicates that a proportional volume of fluid was refilled
from the congested interstitium. Accordingly, it was possi-
ble to calculate the PRR, which progressively decreased
during UF (Fig. 3).
DISCUSSION
Our study confirms that UF is effective in removing fluid in
overhydrated patients with CHF. As previously demon-
strated (3–6,15,16), the procedure induces improvement in
respiratory function and relieves ascites and peripheral
edema. The benefits are usually obtained in a very short
time, particularly if compared with any other available
therapeutic approach. Sometimes, however, prolonged UF
treatment is required. It is known that, in most patients,
diuretic responsivity can be regained; for instance, in this
study, furosemide dosages were reduced by approximately
300% the day after UF. This is important because it allows
for maintenance, and even improvement of, the clinical
benefit achieved at the end of a single session of UF in the
days and months that follow (17). Thus, by restoring
diuresis and diuretic responsiveness, UF is able to interrupt,
and then revert, the vicious circle that leads to refractoriness.
Nevertheless, some concerns still exist in regard to the safety
of the procedure, particularly in patients with impaired
hemodynamic stability and poor cardiac functional reserve,
such as those with rCHF.
Hemodynamic consequences of ultrafiltration. Our study
demonstrates that withdrawal by UF of more than 4 L
of plasma water over a period of a few hours can be safely
performed without detrimental hemodynamic conse-
quences. Indeed, during treatment, heart rate, systemic
arterial pressure, cardiac output and systemic vascular resis-
tances did not change, despite a progressive decline in
ventricular filling pressures. Both cardiac output and stroke
volume significantly increased at the end and, to a greater
extent, 24 h after UF. This apparent paradox indicates
that in rCHF, during UF, the heart is operating on the
horizontal part of the ventricular function curve or that
a reduction of the external work of the heart is occurring
(18,19). Indeed, because right and left heart pressures
reduce in a 1 to 1 fashion (Fig. 2) and not on a 1 to 3
basis, as usually happens when external cardiac constriction
is absent (19,20), a reduction of the extracardiac constraint,
acting on both sides of the heart, is likely. This extra-
cardiac constraint might be due to increased lung water
(6,16,17,21), pleural effusion and ascites (22). Thus, reduc-
tion in the filling pressure of both ventricles and improve-
ment in cardiac performance purely reflect the reduction of
intrathoracic pressure and the removal of its negative influ-
ence on the heart (19,23,24). Indeed, removal of the
constraining effect exerted by the overhydrated lungs on the
heart has been shown to reduce the ventricular filling
pressures and improve diastolic properties of the heart,
which means improved cardiac performance (18).
Blood gas changes induced by ultrafiltration. In addition
to central hemodynamic parameters, we also investigated
the possibility that, in reference to patients with rCHF,
biochemical compensatory mechanisms are elicited in the
periphery during UF. Before treatment, venous PO2 and
hemoglobin saturation, as well as oxygen delivery, were low,
while oxygen extraction ratio and arterial-venous oxygen
difference were increased when compared with normal
subjects (13). This indicates that, when central hemody-
namic impairment occurs and oxygen delivery to peripheral
tissue reduces, activation of peripheral compensatory mech-
anisms, in order to increase oxygen extraction, takes place.
During UF, all these parameters remained stable, suggesting
either no further activation (because of hemodynamic sta-
bility) or the exhaustion of defensive homeostatic mecha-
nisms. The lack of cardiac output and mean systemic arterial
pressure worsening during the procedure did not allow us to
speculate about the exhaustion of homeostatic mechanisms
in rCHF. In contrast, at the end of the treatment, a trend
toward normalization of all these variables, parallel with
oxygen delivery increase, was observed; this implies that
compensatory mechanisms are turned off by UF.
Blood volume adjustments during ultrafiltration. Be-
cause hemodynamic worsening does not take place during
UF, refilling from the extravascular space is adequate to
replace the removed intravascular fluid, and hypovolemia is
prevented (14,25). Adequate refilling, as well as plasma
volume changes, can be easily monitored through an Ht
Figure 2. Right atrial pressure (RAP) versus pulmonary artery wedge
pressure (PWP) during extracorporeal ultrafiltration. Symbols (mean
[black circle] 6 SD [bar]) are, from right to left, data obtained before
ultrafiltration, after 1 L, 2 L, 3 L and 4 L of ultrafiltrate, at the end and
24 h after ultrafiltration. A 1 to 1 reduction of right and left atrial pressures
suggests lowering of extracardiac constraint (see text).
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changes evaluation. In our study, and in others as well
(6,25), Ht did not significantly change despite the large
amount of fluid that was removed. This indicates a propor-
tional shifting of water from the extravascular to the
intravascular phase. If Ht increases, it may indicate either an
insufficient refilling rate in order to compensate an exces-
sively fast fluid withdrawal or the complete removal of the
extravascular edema. In both cases, any further prolongation
of the treatment, or of the same UF speed, would cause a
possibly dangerous hypovolemia-related hypotension and a
cardiac output reduction. Hemodynamic stability, due to
plasma refilling, explains why the procedure can be per-
formed in patients with cardiogenic shock as well (4,10);
again, however, this is true only in the presence of an
extravascular edema able to warrant a sufficient refilling.
Average estimated refilling rate (Fig. 3) during UF progres-
sively declined with time, suggesting that, as extravascular
fluid volume is progressively removed, UF rate has to be
reduced. As a consequence, a close monitoring of plasma
volume changes is required during UF.
In conclusion, our data show that UF, when performed as
a kidney replacement therapy for rCHF, is a safe and
effective procedure that allows the patient to reach a rapid
clinical and hemodynamic improvement. This is associated
with intravascular volume stability, mainly due to adequate
refilling of fluid from the overhydrated interstitium. How-
ever, monitoring of intravascular volume changes is manda-
tory in order to prevent hypovolemia-related hypotension;
this can easily be performed through sequential measure-
ments of the Ht fraction.
Reprint requests and correspondence: Dr. GianCarlo Marenzi,
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Figure 3. Percent changes in plasma volume (PV) (upper) and plasma refilling rate (PRR) (lower) during extracorporeal ultrafiltration (UF). *p , 0.01 vs.
1 L.
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